LFVN 📈 Lifevantage - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US53222K2050
LFVN: Supplements, Nootropics, Probiotics, Weight Management, Skin Care, Hair Care
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement designed to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company is headquartered in Lehi, Utah. Web URL: https://www.lifevantage.com
Additional Sources for LFVN Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
LFVN Stock Overview
Market Cap in USD | 203m |
Sector | Consumer Defensive |
Industry | Packaged Foods |
GiC Sub-Industry | Personal Care Products |
IPO / Inception | 2004-10-05 |
LFVN Stock Ratings
Growth 5y | 11.3% |
Fundamental | 29.7% |
Dividend | 42.3% |
Rel. Strength Industry | 1033 |
Analysts | - |
Fair Price Momentum | 19.04 USD |
Fair Price DCF | 11.13 USD |
LFVN Dividends
Dividend Yield 12m | 0.89% |
Yield on Cost 5y | 1.13% |
Annual Growth 5y | 143.81% |
Payout Consistency | 66.7% |
LFVN Growth Ratios
Growth Correlation 3m | 90.7% |
Growth Correlation 12m | 88.6% |
Growth Correlation 5y | -34.3% |
CAGR 5y | 4.90% |
CAGR/Mean DD 5y | 0.09 |
Sharpe Ratio 12m | 1.91 |
Alpha | 168.45 |
Beta | 0.68 |
Volatility | 77.01% |
Current Volume | 77.2k |
Average Volume 20d | 93.3k |
What is the price of LFVN stocks?
As of December 22, 2024, the stock is trading at USD 17.36 with a total of 77,178 shares traded.
Over the past week, the price has changed by +8.23%, over one month by +34.63%, over three months by +61.48% and over the past year by +183.69%.
As of December 22, 2024, the stock is trading at USD 17.36 with a total of 77,178 shares traded.
Over the past week, the price has changed by +8.23%, over one month by +34.63%, over three months by +61.48% and over the past year by +183.69%.
Is Lifevantage a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Lifevantage is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 29.67 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LFVN as of December 2024 is 19.04. This means that LFVN is currently overvalued and has a potential downside of 9.68%.
Neither. Based on ValueRay Fundamental Analyses, Lifevantage is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 29.67 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LFVN as of December 2024 is 19.04. This means that LFVN is currently overvalued and has a potential downside of 9.68%.
Is LFVN a buy, sell or hold?
Lifevantage has no consensus analysts rating.
Lifevantage has no consensus analysts rating.
What are the forecast for LFVN stock price target?
According to ValueRays Forecast Model, LFVN Lifevantage will be worth about 20.9 in December 2025. The stock is currently trading at 17.36. This means that the stock has a potential upside of +20.28%.
According to ValueRays Forecast Model, LFVN Lifevantage will be worth about 20.9 in December 2025. The stock is currently trading at 17.36. This means that the stock has a potential upside of +20.28%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7 | -59.7% |
Analysts Target Price | 7 | -59.7% |
ValueRay Target Price | 20.9 | 20.3% |